MORPHOTEK, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 26110
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 25230
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 20147
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9197
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 891
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4121
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
A01H NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES 1127
 
  
 
B82Y SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE  OR TREATMENT OF NANO-STRUCTURES152

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0311,921 METHODS FOR TREATMENT OF OVARIAN CANCERJun 20, 14Oct 27, 16[A61K, G01N, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9915660 Methods for determining prognosis of colorectal cancerMar 15, 14Mar 13, 18[G01N]
9868780 enterotoxin BMay 02, 16Jan 16, 18[A61K, C07K]
9771429 TEM-1 diagnostic antibodiesAug 12, 15Sep 26, 17[G01N, C07K]
9650440 Monoclonal antibodies that specifically block biological activity of a tumor antigenMar 14, 13May 16, 17[A61K, C07K]
9637526 Chlorotoxin polypeptides and conjugates and uses thereofDec 01, 15May 02, 17[A61K, G01N, C07K]
9624297 Monoclonal antibodies that specifically block biological activity of a tumor antigenJul 09, 09Apr 18, 17[A61K, C07K]
9603952 Treatment of metastatic tumorsMay 04, 15Mar 28, 17[C07H, A61K, C12N]
9522195 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cellsJul 27, 15Dec 20, 16[A61K, B82Y, C07K]
9512223 Methods for treatment of gastric cancerMar 14, 13Dec 06, 16[A61K, G01N, C07K]
9505842 Methods for inhibiting the binding of endosialin to ligandsOct 08, 14Nov 29, 16[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0212,410 CO-ADMINISTRATION OF ERIBULIN AND FARLETUZUMAB FOR THE TREATMENT OF BREAST CANCERAbandonedMar 02, 13Jul 31, 14[A61K]
2013/0305,396 ENGINEERED HUMAN ENDOSIALIN-EXPRESSING RODENTSAbandonedSep 28, 11Nov 14, 13[A61K]
8507657 Anti-GD2 antibodiesExpiredAug 23, 12Aug 13, 13[C12P, C07K]
8278065 Polynucleotides encoding anti-GD2 antibodiesExpiredJun 30, 09Oct 02, 12[C12P, C12N]
2012/0207,771 FOLATE RECEPTOR ALPHA AS A DIAGNOSTIC AND PROGNOSTIC MARKER FOR FOLATE RECEPTOR ALPHA-EXPRESSING CANCERSAbandonedNov 04, 11Aug 16, 12[A61K, G01N, A61P]
2012/0164,137 ANTI-FOLATE RECEPTOR ALPHA ANTIBODY GLYCOFORMSAbandonedOct 19, 11Jun 28, 12[A61K, C12P, C12N, G01N, A61P, C07K]
2012/0156,131 DIAGNOSIS AND TREATMENT OF TUMORSAbandonedJun 14, 11Jun 21, 12[A61K, G01N, A61P]
2011/0311,445 DIAGNOSIS AND TREATMENT OF MYELOID AND LYMPHOID CELL CANCERSAbandonedMay 09, 11Dec 22, 11[A61K, G01N, A61P]
2011/0091,380 CHLOROTOXINS AS DRUG CARRIERSAbandonedAug 07, 08Apr 21, 11[A61K, C12N, A61P, C07K]
2010/0260,769 ENDOSIALIN BINDING MOLECULESAbandonedApr 08, 10Oct 14, 10[A61K, C12P, C12N, G01N, A61P, C07K]
2010/0215,575 Systemic Administration of Chlorotoxin Agents for the Diagnosis and Treatment of TumorsAbandonedOct 10, 08Aug 26, 10[A61K, A61P]
2010/0210,546 COMBINATION CHEMOTHERAPY WITH CHLOROTOXINAbandonedApr 07, 10Aug 19, 10[A61K]
2010/0021,996 Genetically Altered Anti-body Producing Cell Lines With Improved Antibody CharacteristicsAbandonedSep 24, 09Jan 28, 10[C12N]
7604994 Genetically altered antibody-producing cell lines with improved antibody characteristicsExpiredSep 02, 04Oct 20, 09[C12N]
2008/0153,746 Diagnosis and Treatment of Myeloid and Lymphoid Cell CancersAbandonedApr 06, 05Jun 26, 08[A61K, G01N, A61P]
2008/0131,427 Whole Genome Evolution Technology Applied To Improve Protein And Antibody Yields By CellsAbandonedApr 16, 07Jun 05, 08[A61K, C12N]
2008/0124,744 Antibodies That Specifically Bind PMS2AbandonedDec 21, 07May 29, 08[G01N]
2007/0275,902 Treatment of Phosphatidylinositol Phospholipid DisordersAbandonedNov 23, 04Nov 29, 07[A61K, C12N, G01N, A61P]
2007/0237,714 Diagnosis and treatment of tumorsAbandonedMar 30, 07Oct 11, 07[A61K]
2007/0065,904 Recombinant expression vectors for functional nav1.9 sodium channelsAbandonedMar 20, 03Mar 22, 07[C07H, C12N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.